Virginia Oncology Associates

What Virginia Oncology Associates does

Virginia Oncology Associates (VOA) is a community-based, private oncology and hematology physician practice headquartered in Norfolk, Virginia. Founded in 1980 by physicians from the Hampton Roads area, VOA operates 9 locations across southeast Virginia (Norfolk, Virginia Beach, Chesapeake, Suffolk, Hampton, Newport News, Williamsburg) and Northeast North Carolina (Elizabeth City), staffed by more than 45 board-certified cancer and blood disease specialists with over 450 years of combined experience. The practice delivers comprehensive multidisciplinary cancer care including chemotherapy, immunotherapy, CAR-T cell therapy, stem cell transplantation, targeted therapy, hormone therapy, and radiation therapy (utilizing TrueBeam Linear Accelerator, SRS, SBRT, and HDR brachytherapy), supported by in-house clinical laboratory, genetic and genomic testing, diagnostic imaging, and an in-office pharmacy/dispensary network.

VOA's service platform extends beyond direct treatment to include nurse navigation, oncology social workers, palliative care, nutrition counseling, advance care planning, telehealth via pMD, a Navigating Care patient portal, and the C.A.R.E. Clinic for urgent oncology-related issues. The practice participates in Phase I-III clinical trials through Sarah Cannon Research Institute, NCI Cooperative Groups, Eastern Virginia Medical School, and Duke Oncology Network, and partners with Cerula Care for behavioral health integration — a program that has enrolled over 850 patients. VOA is a member of The US Oncology Network, supported by McKesson Corporation, which connects it to more than 3,300 independent providers for value-based, integrated care delivery.

The revenue model is insurance-based fee-for-service billing (Medicare, Medicaid, and commercial carriers including Aetna, Anthem, Blue Cross Blue Shield, CIGNA, Humana, United Healthcare, Optima, Tricare, and Virginia Premier) supplemented by clinical research program revenue. Patient acquisition occurs primarily through physician referral networks, with secondary channels including second-opinion consultations, community outreach, and digital content marketing via the Cancer Care Connections Podcast and patient education blog. The practice holds QOPI Certification and operates under HIPAA compliance.

Name

Virginia Oncology Associates

Legal name

Virginia Oncology Associates

Website

https://virginiacancer.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Virginia Oncology Associates is a private, community-based oncology and hematology practice operating 9 locations across Hampton Roads, Virginia and Northeast North Carolina with 46 board-certified physicians delivering comprehensive multidisciplinary cancer care and clinical trial access.

Ownership category

akta.pro rank

Product category

Oncology and Hematology Healthcare Services

NAICS

Offices of Physicians (62111), Other Ambulatory Health Care Services (6219)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC)

Keywords

• Community oncology care
• Hematology treatment services
• Cancer clinical trials
• Radiation oncology therapy
• Cancer diagnostics imaging

Headquarters

HQ city

Norfolk

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Patient Care Services: Virginia Oncology Associates generates revenue through direct patient care services including office visits, chemotherapy administration, radiation therapy, laboratory services, diagnostic imaging, and other oncology treatments. Services are billed to insurance carriers including Medicare, Medicaid, and commercial insurers. The practice participates in most major insurance networks and files claims on behalf of patients.
2. Clinical Research Programs: VOA participates in clinical trials through affiliations with Sarah Cannon Research Institute and other research organizations, providing access to investigational therapies while generating research-related revenue streams.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Virginia Oncology Associates provides comprehensive, multidisciplinary cancer and hematology care through 46 board-certified physicians across 9 community-based locations. The practice delivers treatments including chemotherapy, immunotherapy, targeted therapy, hormone therapy, cellular therapies, stem cell transplantation, and radiation therapy, complemented by diagnostic services, clinical research trials, and patient support services.

Product overview

Virginia Oncology Associates is a community-based oncology and hematology practice offering comprehensive cancer care across Hampton Roads, Virginia and Northeastern North Carolina. The practice operates as a unified care platform with multiple treatment services (Chemotherapy, Immunotherapy, Cellular Therapies & Transplant, Targeted Therapy, Hormone Therapy, Radiation Therapy) combined with diagnostic services (Clinical Laboratory, Genetic Testing, Genomic Testing, Diagnostic Imaging), support services (Nutrition Counseling, Nurse Navigators, Social Workers, Palliative Care, Advance Care Planning), and patient access services (Telehealth, Patient Portal, Pharmacy). Key specialized offerings include the C.A.R.E. Clinic for urgent oncology care, a robust Clinical Trials Research program, and Tumor Board multidisciplinary care coordination. With 46 physicians across 9 locations, VOA provides integrated, compassionate, state-of-the-art care for patients with cancer and blood disorders.

Differentiator

Problem solved

Functional benefit

Brands

• C.A.R.E. Clinic: Comprehensive Assessment Rapid Evaluation Clinic - a specialized urgent care facility for established VOA patients providing timely care for acute issues related to cancer or its treatment.

Products and services

• Chemotherapy A group of medicines used to treat cancer that works throughout the body to destroy cancer cells that have spread from the original tumor site. Administered via pill, shot, or IV to oncology patients.
• Immunotherapy Immuno-Oncology (I-O) therapy using drugs that target a patient's own immune system to help fight cancer, particularly effective for certain cancer types.
• Cellular Therapies & Transplant Includes CAR T-cell therapy and stem cell transplantation for treating blood cancers and hematologic conditions. CAR T-cell therapy modifies patient T-cells to recognize and destroy cancer cells.
• Targeted Therapy Drugs or substances that block cancer growth and spread by interfering with specific molecules involved in tumor growth, including tyrosine kinase inhibitors and monoclonal antibodies.
• Hormone Therapy A systemic cancer treatment that blocks or alters hormones to slow or stop cancer growth, particularly for hormone-sensitive breast and prostate cancers.
• Radiation Therapy High-energy radiation to kill cancer cells while sparing surrounding healthy tissue. Includes external beam radiation, AccuBoost, HDR brachytherapy, stereotactic radiosurgery, SBRT, and radiopharmaceuticals, using TrueBeam Linear Accelerator technology.
• Clinical Trials Research Access to Phase I-III clinical trials through Sarah Cannon Research Institute, NCI Cooperative Groups, Eastern Virginia Medical School, and Duke Oncology Network, offering treatment, prevention, screening, and quality of life trials.
• Clinical Laboratory In-house laboratory providing quick results for routine tests to help physicians prescribe appropriate treatments as soon as possible.
• Genetic Testing Identifies inherited gene mutations that may put individuals at higher risk for developing cancers such as breast, ovarian, colon, and prostate cancer. Includes genetic counseling services.
• Genomic Testing Genomic tumor assessment performed on cancerous tissue to provide information on how the tumor might behave, including aggressiveness and likelihood of spread.
• Diagnostic Imaging Vital imaging tests and scans for accurately diagnosing and staging cancer as well as tracking treatment progress.
• Nutrition Counseling Personal nutrition solutions and menu ideas to prevent additional illnesses and facilitate recovery during cancer treatment.
• Nurse Navigators Registered nurses specializing in oncology who guide patients through the full continuum of care from detection and diagnosis to treatment and survivorship.
• Oncology Social Workers Support services for emotional, practical, and resource needs including financial concerns, insurance barriers, transportation, housing, and emotional/mental health support.
• Palliative Care Holistic approach to address symptom assessment and management including pain, nausea, fatigue, and emotional needs while assisting with decision-making and establishing goals of care.
• Advance Care Planning Helps patients understand treatment options and create plans for medical care, including assistance with creating Advance Directive documents.
• C.A.R.E. Clinic Comprehensive Assessment Rapid Evaluation clinic - specialized urgent care facility for established oncology patients providing same-day/next-day appointments for acute issues including weakness, rashes, dehydration, nausea, DVT, and febrile neutropenia.
• Telehealth Virtual appointments using live audio/video technology via pMD platform for routine office visits, providing safety and convenience for patients.
• Navigating Care Patient Portal Digital health companion providing 24/7 secure online access for patients to manage their care, view health records, appointments, securely message care team, and access education materials.
• Pharmacy & In-Office Dispensary Retail pharmacy services at Brock Cancer Center, Harbour View, and Port Warwick offices, plus In-Office Dispensing at Hampton location. Offers prior authorization, co-pay assistance, and biosimilar medications.
• Tumor Board Multidisciplinary treatment planning approach where experts from different specialties review and discuss patient cases to identify the best possible treatment plans.
• Cancer Support Groups & Resources Comprehensive support including support groups, caregiver resources, disease-specific organizations, survivorship information, and community partnerships for cancer patients and families.

Quantifiable outcome

• 62% reduction in depression symptoms and 57% reduction in anxiety within four months through behavioral health integration program

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Cerula CarecoreStrategic or Co-development Partner · 1 January 2024Partnership established January 2024 for behavioral health integration in cancer care. The collaborative care program has enrolled over 850 patients and demonstrated clinically significant outcomes including 62% reduction in depression symptoms and 57% reduction in anxiety within four months. A joint podcast explores perspectives on addressing mental health alongside cancer treatment.
• The US Oncology NetworkcoreStrategic or Co-development PartnerVirginia Oncology Associates is a practice in The US Oncology Network, united with more than 3,300 independent providers dedicated to delivering value-based, integrated care to patients close to home. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors to focus on patient health while McKesson focuses on practice health.
• Sentara Health SystemcoreStrategic or Co-development PartnerCollaboration with Sentara Health System for Radiation Therapy services brings multiple disciplines oriented towards streamlining, simplifying, and personalizing cancer care. This collaboration allows multimodality treatments under one roof, improving efficiency of complicated care protocols.
• Sarah Cannon Research Institute (SCRI)coreStrategic or Co-development PartnerVirginia Oncology Associates participates in clinical trials through SCRI, one of the world's leading oncology research organizations conducting community-based clinical trials. SCRI has contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today.
• Eastern Virginia Medical SchoolminorStrategic or Co-development PartnerCollaboration with Eastern Virginia Medical School allows students and postdoctoral trainees to avail themselves of VOA physicians' expertise in their instructional process, meeting VOA's goals as a community educator.
• Duke UniversityminorStrategic or Co-development PartnerCollaborative efforts with Duke University in research and continuing education further meet VOA's goals of comprehensive services to the community.
• McKesson CorporationcoreOthersMcKesson Corporation provides coordinated resources and infrastructure supporting The US Oncology Network, allowing independent oncology practices like VOA to focus on patient health while McKesson supports practice operations.

Scale indicators6 records

Recent moves6 records

Broad incumbents

• The US Oncology Network: Network platform supported by McKesson that VOA is a member of; broadly consolidates 3,300+ independent oncology providers. Less direct as a peer but materially relevant context given VOA's operating model.

Others

• Sentara Healthcare: Regional health system that VOA collaborates with on radiation therapy services and that operates competing cancer service lines in Hampton Roads. Represents a hospital-system oncology counterweight and a regional collaborator.
• Eastern Virginia Medical School: Academic medical institution that VOA partners with for medical education and clinical training in the Hampton Roads region. Provides workforce pipeline and research collaboration that anchors VOA's regional talent supply.
• Sarah Cannon Research Institute: Community-based clinical research organization that conducts trials on behalf of US Oncology Network practices including VOA. Relevant research partner rather than direct competitor.

Direct peers

• Tennessee Oncology: Community oncology practice affiliated with Sarah Cannon, also part of The US Oncology Network. Provides medical oncology, radiation oncology, and clinical trials in a regional US market — highly comparable in research affiliation and community-care delivery.
• Florida Cancer Specialists & Research Institute: Large community-based hematology/oncology practice with broad Florida footprint, in-house pharmacy, and clinical research participation. Comparable in service breadth, payor mix, and physician-employment scale.
• New York Oncology Hematology (NYOH): Regional community oncology practice with multiple sites across upstate New York offering medical oncology, hematology, and clinical trials. Similar US Oncology Network affiliation and community-based delivery model.
• Texas Oncology: Largest community-based oncology practice in the US and a fellow member of The US Oncology Network. Operates dozens of sites across Texas with medical oncology, radiation oncology, diagnostics, and clinical research — closest direct comparable to VOA's community-multidisciplinary model.
• Comprehensive Cancer Centers of Nevada: Multi-site community oncology and hematology practice in Nevada with integrated diagnostics, radiation, and clinical research. Comparable community multispecialty oncology model and payer mix.

Emerging players

• Duke Cancer Institute / Duke Oncology Network: Academic oncology center with a community affiliate network that VOA participates in. Represents both a research partner and a higher-acuity alternative referral destination for Hampton Roads patients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubefeeds.buzzsprout.com/2167428.rss

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Virginia Oncology Associates